David Spaight

Oncology Analytics, Inc. provides oncology benefits management solutions. Its services include rapid, easy-to-use prior authorization services with proven ROI, clinical decision support, physician education and expert peer review, oncology network evaluation and optimization consulting services, patented, value-based reimbursement methods and tools and comprehensive performance reporting and analytics. The company was founded by Marc Fishman, Ann Huntress Lamont and Danielle Fishman in 2009 and is headquartered in Plantation, FL.

Part of CellCarta Biosciences, Inc., HistoGenex Holding NV is an investment holding Belgian company. The company is based in Antwerp, Belgium. Founded in 2015.

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

Part of CellCarta Biosciences, Inc., HistoGenex Holding NV is an investment holding Belgian company. The company is based in Antwerp, Belgium. Founded in 2015.

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

Oncology Analytics, Inc. provides oncology benefits management solutions. Its services include rapid, easy-to-use prior authorization services with proven ROI, clinical decision support, physician education and expert peer review, oncology network evaluation and optimization consulting services, patented, value-based reimbursement methods and tools and comprehensive performance reporting and analytics. The company was founded by Marc Fishman, Ann Huntress Lamont and Danielle Fishman in 2009 and is headquartered in Plantation, FL.

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

Oncology Analytics, Inc. provides oncology benefits management solutions. Its services include rapid, easy-to-use prior authorization services with proven ROI, clinical decision support, physician education and expert peer review, oncology network evaluation and optimization consulting services, patented, value-based reimbursement methods and tools and comprehensive performance reporting and analytics. The company was founded by Marc Fishman, Ann Huntress Lamont and Danielle Fishman in 2009 and is headquartered in Plantation, FL.

Oncology Analytics, Inc. provides oncology benefits management solutions. Its services include rapid, easy-to-use prior authorization services with proven ROI, clinical decision support, physician education and expert peer review, oncology network evaluation and optimization consulting services, patented, value-based reimbursement methods and tools and comprehensive performance reporting and analytics. The company was founded by Marc Fishman, Ann Huntress Lamont and Danielle Fishman in 2009 and is headquartered in Plantation, FL.

Oncology Analytics, Inc. provides oncology benefits management solutions. Its services include rapid, easy-to-use prior authorization services with proven ROI, clinical decision support, physician education and expert peer review, oncology network evaluation and optimization consulting services, patented, value-based reimbursement methods and tools and comprehensive performance reporting and analytics. The company was founded by Marc Fishman, Ann Huntress Lamont and Danielle Fishman in 2009 and is headquartered in Plantation, FL.

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

Oncology Analytics, Inc. provides oncology benefits management solutions. Its services include rapid, easy-to-use prior authorization services with proven ROI, clinical decision support, physician education and expert peer review, oncology network evaluation and optimization consulting services, patented, value-based reimbursement methods and tools and comprehensive performance reporting and analytics. The company was founded by Marc Fishman, Ann Huntress Lamont and Danielle Fishman in 2009 and is headquartered in Plantation, FL.

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

Part of CellCarta Biosciences, Inc., HistoGenex Holding NV is an investment holding Belgian company. The company is based in Antwerp, Belgium. Founded in 2015.